Does Capnography Prevent Hypoxemia During Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound?
1 other identifier
interventional
263
1 country
1
Brief Summary
Subjects undergoing elective ERCP and EUS will receive standard monitoring and sedation. In addition, capnography which measures carbon dioxide levels and can graphically assess respiratory activity will be used. Subjects will be randomized to either a capnography blinded or titration arm. In the capnography titration arm, the endoscopy team would be made aware of capnographic abnormalities as they arise throughout the procedure. In the capnography blinded arm, this information will not be available to the endoscopy team and represents standard of care. It is our hypothesis that using capnography can prevent low oxygen levels known as hypoxemia, during these procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2006
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2006
CompletedFirst Submitted
Initial submission to the registry
March 30, 2008
CompletedFirst Posted
Study publicly available on registry
May 9, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2008
CompletedResults Posted
Study results publicly available
May 30, 2017
CompletedNovember 28, 2017
October 1, 2017
2 years
March 30, 2008
April 20, 2017
October 24, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants Experiencing Hypoxemia During Endoscopy
Hypoxemia was defined as oxygen saturation less than 90 percent for at least 15 seconds.
Continuously Assessed during a single endoscopic procedure, typically about 2 hours
Secondary Outcomes (3)
Proportion of Participants Requiring Supplemental Oxygen
Continuously measured during endoscopy, typically about 2 hours
Proportion of Participants Experiencing Severe Hypoxemia
Continuously measured during endoscopy, typically about 2 hours
Proportion of Participants Experiencing Apnea
Continuously measured during endoscopy, typically about 2 hours
Study Arms (2)
Capnography
ACTIVE COMPARATORCapnography: Subjects randomized to capnography-titration arm: The endoscopy team would be made aware of the capnographic abnormalities as they arise. In this arm, the endoscopy team will have the graphic representation of respiratory activity (capnography) as well as end-epxiratory levels of carbon dioxide in addition to the normal physiologic monitoring portfolio of pulse oximetry, blood pressure and electrocradiography. This observation phase would take place for a baseline prior to sedation, during the administration of sedation as well as throughout the procedure. Monitoring for the study would stop upon completion of the endoscopic procedure.
Standard Monitoring
NO INTERVENTIONSubjects randomized to capnography-blinded arm: In this arm, the endoscopy team will not have the graphic representation of respiratory activity (capnography) as well as end-expiratory levels of carbon dioxide available. Only a standard of care physiologic monitoring portfolio of pulse oximetry, blood pressure and electrocradiography at the disposal of the endoscopy team to titrate the sedative medications.
Interventions
Capnography: Passive measurement of carbon dioxide via a special bite block which allows graphic assessment of the subject's respiratory activity
Eligibility Criteria
You may qualify if:
- Adults age 18 or greater
- Subjects undergoing elective ERCP and EUS
- ASA class 1-3
- Inpatient and outpatient
- Able to give informed consent
You may not qualify if:
- ASA Class 4 and 5
- Emergent procedures
- Procedures requiring MAC sedation
- Subjects unable to give informed consent
- Subjects on oxygen before procedure
- Subjects on CPAP/BiPAP
- Allergies to fentanyl/demerol/midazolam
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
Related Publications (1)
Qadeer MA, Vargo JJ, Dumot JA, Lopez R, Trolli PA, Stevens T, Parsi MA, Sanaka MR, Zuccaro G. Capnographic monitoring of respiratory activity improves safety of sedation for endoscopic cholangiopancreatography and ultrasonography. Gastroenterology. 2009 May;136(5):1568-76; quiz 1819-20. doi: 10.1053/j.gastro.2009.02.004.
PMID: 19422079DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. John Vargo
- Organization
- Cleveland Clinic
Study Officials
- PRINCIPAL INVESTIGATOR
John J Vargo, M.D., M.P.H.
The Cleveland Clinic
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 30, 2008
First Posted
May 9, 2008
Study Start
September 1, 2006
Primary Completion
September 1, 2008
Study Completion
September 1, 2008
Last Updated
November 28, 2017
Results First Posted
May 30, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share